Veterinary Vaccines Market – Trends Forecast Till 2031

Market Snapshot

Market Overview

The global Veterinary Vaccines Market size was estimated at USD 8,930 million in 2024 and is projected to reach USD 12,733.9 million in 2031 at a CAGR of 5.20 % during the forecast period 2025-2031.

The global veterinary vaccines market refers to the segment of the healthcare industry focused on the development, production, and distribution of vaccines designed to prevent infectious diseases in animals. These vaccines are critical in protecting livestock, pets, and wildlife from a wide array of diseases that could otherwise have significant economic, environmental, and public health consequences. The market encompasses both companion animal vaccines, which protect pets like dogs and cats, and livestock vaccines aimed at cattle, poultry, swine, and other farm animals. Veterinary vaccines play a pivotal role in disease prevention, promoting animal health, and ensuring food security.

The scope of the global veterinary vaccines market is expanding due to several factors. Increased awareness of animal health, growing concerns about zoonotic diseases, and rising pet ownership have spurred demand for vaccines across various regions. Technological advancements in vaccine development, such as recombinant DNA technology, mRNA vaccines, and improved delivery systems, have enhanced the effectiveness and safety of vaccines. Additionally, regulatory support and government initiatives aimed at improving animal health standards have contributed to the market's growth. The adoption of vaccines in developing countries is also rising, driven by increasing agricultural practices and the need to protect both livestock and poultry from costly diseases.

Several trends are shaping the global veterinary vaccines market. One prominent trend is the rising focus on the development of vaccines for companion animals, driven by the growing pet population and the increasing willingness of pet owners to invest in preventative healthcare. Another trend is the integration of digital technologies in vaccine development and monitoring, such as artificial intelligence and data analytics, to improve production efficiency and effectiveness. Additionally, the growing awareness about antimicrobial resistance has led to an increased preference for vaccines as a preventive measure over antibiotic treatments, further boosting market demand.

Key drivers of the veterinary vaccines market include the increasing global demand for animal-derived food products, the rising incidence of animal diseases, and the need to prevent the transmission of zoonotic diseases that can affect humans. Additionally, the expanding veterinary healthcare infrastructure in emerging economies and the growing investments in research and development to create more effective vaccines are driving the market forward. With an emphasis on sustainability, the market is also moving towards vaccines that are safer for animals, humans, and the environment, promoting long-term industry growth and development.

Delvens Industry Expert's Standpoint

Experts in the Global Veterinary Vaccines Market highlight several key trends driving growth and innovation. The global veterinary vaccines market focuses on the development and distribution of vaccines to prevent diseases in animals, including both companion animals and livestock. Driven by factors such as increasing pet ownership, growing awareness of animal health, and concerns over zoonotic diseases, the market is expanding globally. Technological advancements in vaccine development and regulatory support are key growth factors, while trends like the focus on companion animal vaccines, the integration of digital technologies, and a preference for vaccines over antibiotics are shaping the industry. Market drivers include rising demand for animal-derived food, the need to combat animal diseases, and the growing emphasis on sustainability and more effective, safer vaccines.

Market Portfolio

Key Findings

• The livestock vaccines segment is projected to remain the largest in the global veterinary vaccines market, driven by the increasing demand for animal-derived food products and the growth of livestock farming. As livestock are raised primarily for meat and dairy production, there is a strong focus on maintaining animal health to prevent disease outbreaks and improve productivity. This is further supported by the growing industrialization of farming and more stringent government regulations on livestock health. The rising demand for meat, particularly in regions like the United States, coupled with policies promoting animal health and food safety, will continue to drive the need for livestock vaccines.

• The companion animal vaccines segment is also expected to witness significant growth, fueled by the increasing pet population and the rising awareness of pet healthcare. Pet owners are becoming more proactive in ensuring the well-being of their animals, leading to higher vaccination rates. The growing focus on preventive healthcare for pets, along with technological advancements in vaccine development, is boosting the demand for vaccines designed for companion animals. As pets continue to be viewed as integral members of families, the demand for effective, safe vaccines will increase, contributing to the growth of this segment.

• The veterinary hospitals segment, as the primary end user of veterinary vaccines, is expected to hold the largest share of the market. This is due to the rising ownership of companion animals, the increasing population of livestock, and the growing demand for animal-derived food in emerging economies, all of which drive the need for veterinary care. Veterinary hospitals are the main healthcare providers for diagnosing and treating animals, and their services are crucial for administering vaccines. Additionally, the availability of professional veterinary staff and the rising awareness of animal health in developed markets, where pet owners are more willing to spend on regular check-ups and treatment, will continue to boost the growth of this segment.

• The diagnostic laboratories segment is also projected to experience growth, as these facilities play a crucial role in identifying diseases in animals and ensuring the efficacy of vaccines. Veterinary diagnostic laboratories help in early detection and diagnosis, which is essential for preventing outbreaks and controlling the spread of animal diseases. The increased focus on improving animal health, particularly in regions with large livestock populations, is driving the demand for diagnostic services to complement vaccination programs. As veterinary diagnostics evolve and become more sophisticated, the role of these laboratories in supporting vaccine development and distribution will further enhance their importance in the market.

• The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America region is projected to hold the largest market share. Factors such as increased demand for animal-derived food, rising livestock farming, growing pet ownership, technological advancements, government regulations, awareness of animal health, expanding veterinary infrastructure, focus on disease prevention, emerging markets, zoonotic disease awareness, preventive healthcare adoption, and livestock farming industrialization have triggered the Global Veterinary Vaccines Market in the region.

Regional Analysis

North America to Dominate the Market

• North America is expected to maintain a leading position in the global animal vaccines market, driven by the high prevalence of livestock and zoonotic diseases that result in significant animal losses. The presence of major pharmaceutical companies and a robust pet population, especially in the United States, contributes to increased vaccine adoption, particularly for pets suffering from canine diseases. The region's well-established infrastructure for animal health and government policies promoting disease prevention are also key factors bolstering market growth.

• In Europe, the animal vaccines market is set to grow steadily, supported by the large populations of both production and companion animals. The region boasts significant pet ownership, with millions of households owning pets, which drives demand for vaccines. Regulatory bodies like the European Medicines Agency are actively working to improve vaccine availability, further supporting the market. Additionally, countries like Germany, with a large cattle population and a strong focus on preventive care for both farm and companion animals, are contributing to the market's expansion.

• The Asia Pacific region is expected to witness the fastest growth in the animal vaccines market, driven by the increasing livestock population and strong government initiatives, particularly in developing economies. The rise in cattle populations and the subsequent need for vaccines is a key factor, alongside substantial investments in research and development. Japan’s pet industry, characterized by a high pet-to-child ratio and growing pet healthcare expenditure, is also set to contribute significantly to the market's growth in the region.

• Latin America is anticipated to experience notable market growth, fuelled by ongoing healthcare reforms and rising awareness about livestock health. Countries like Brazil, with a large cattle population and growing export demand for beef, are driving the need for veterinary vaccines. Government support, especially in combating chronic livestock diseases, and economic growth in the region are expected to further propel the market. Increased focus on vaccination to manage disease outbreaks in livestock also supports this trend in Latin America.

• The Middle East & Africa region is projected to see steady growth in the animal vaccines market, particularly in South Africa, Saudi Arabia, the UAE, and Kuwait. The market growth is attributed to the high prevalence of diseases such as foot-and-mouth disease and animal influenza, along with rising awareness about animal health. South Africa, with its significant livestock production, especially poultry, benefits from government initiatives aimed at improving animal healthcare, further driving the demand for vaccines in the region.

Competitive Landscape

• Zoetis
• Merck & Co., Inc.
• Boehringer Ingelheim
• Elanco
• Virbac
• Ceva
• Phibro Animal Health
• Hester Biosciences
• Neogen
• HIPRA
• Biogénesis Bagó
• Tianjin Ringpu
• China Animal Husbandry
• Jinyu Bio-technology
• Vaxxinova International

Recent Developments

• In November 2024, Ceva (France) announced the construction of a new vaccine manufacturing facility in Monor, Hungary. The 7,000 m² plant will feature state-of-the-art technologies and focus on producing fermentation-based multicomponent inactivated vaccines for animals, enhancing Ceva's global production capacity.

• In September 2024, Merck & Co., Inc. (US) revealed the expansion of its NOBIVAC NXT platform with the introduction of a pioneering new vaccine for Feline Leukemia Virus (FeLV). This vaccine is the first to utilize RNA-Particle Technology, providing a novel solution for preventing FeLV in cats.

• In November 2024, Boehringer Ingelheim International GmbH (Germany) launched the EURICAN L4 vaccine, aimed at protecting dogs from leptospirosis, a reemerging and severe infectious disease that poses a growing threat to canine health.

Reasons to Acquire

• Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
• Gain authentic and granular data access for the Global Veterinary Vaccines Market to understand the trends and the factors involved in changing market situations.
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.

Report Scope